ArticleNeurosurgical review2025
Dynamic sodium dysregulation predicts mortality in intracerebral hemorrhage: A retrospective cohort study of temporal variability and absolute thresholds.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Predicting Blood Pressure and Blood Pressure Variability in Spontaneous Intracerebral Hemorrhage in the Emergency Department Using Machine Learning.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dysnatremia and sodium variability are emerging prognostic markers in neurocritical care, yet their role in intracerebral hemorrhage (ICH) remains underexplored. This study investigates the independent and synergistic effects of serum sodium variability (coefficient of variation, CV) and absolute sodium levels on mortality in ICH patients. We conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database. Sodium variability was quantified as CV, while mean sodium levels were categorized into normonatremia (135-145 mmol/L), hyponatremia (< 135 mmol/L), and hypernatremia (> 145 mmol/L). Outcomes included 30-day, in-hospital, and ICU mortality. Multivariable Cox models adjusted for demographics, disease severity, and interventions. A total of 2044 ICH patients were included in the study. Increased sodium variability exhibited a robust linear association with mortality, with each 1% rise in CV independently predicting a 38% higher 30-day mortality risk (adjusted HR 1.38, 95% CI 1.31-1.46; P < 0.001). Patients in the highest CV quartile (Q4) faced a 2.48-fold mortality risk compared to the lowest quartile (Q1). Hypernatremia (> 145 mmol/L) emerged as a potent independent predictor of mortality (HR 2.93, 95% CI 2.43-3.52; P < 0.001), whereas hyponatremia showed non-significant trends (HR 1.17, 0.85-1.61). Restricted cubic spline analyses revealed a U-shaped relationship between mean sodium levels and mortality, with 140.7 mmol/L as the optimal threshold, while sodium variability demonstrated a linear dose-response effect. Both sodium variability and hypernatremia independently predict mortality in ICH, with CV demonstrating a linear dose-response relationship and absolute levels showing a U-shaped risk curve. These findings advocate for dual monitoring of sodium homeostasis to guide precision fluid management in ICH.
Indexed as
Identifiers
40839125What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.